The products are being advertised as more affordable alternatives to blockbuster weight-loss drugs. Here’s what doctors think ...

One of the biopharma industry’s marvels of the 2020s has been the enormous medical and financial success of the GLP-1 class ...

In early-stage trials, oral weight-loss drugs from Eli Lilly and Novo Nordisk have shown that they can help patients achieve ...

Why fork over thousands of dollars a month for prescription weight loss jabs when store-bought supplements claim to have the ...

Certain blockbuster weight-loss drugs have been found to protect the heart in significant ways, and new research suggests ...

In an unconventional alliance, North Carolina State Treasurer Dale Folwell, a Republican, spoke on Capitol Hill at a ...

Incretins are not just metabolic hormones that regulate glucose levels after eating. Their functions go beyond stimulating ...

On the heels of disappointing low-dose data results, Zealand Pharma is back with separate findings for its GLP-1/GLP-2 ...

Novo Nordisk A/S's shares have stalled recently, but this looks like a natural digestion of gains from prior years. Click for ...

Roughly three-quarters of people who took both an injectable and pill version of a new GLP-1 weight loss drug in trials ...

Data from the US FDA's Adverse Event Reporting System on tirzepatide showed adverse events generally consistent with those ...